ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Ohio State, Hawaii Name New Center Directors; Berlin Acting Director At Papanicolaou

July 29, 1988

NCI To Recomplete CIDAC Contracts

September 23, 1977

ACCC To Present Program On Impact Of New Technology

January 23, 1981

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

NCI To Send Eight To AIDS Conference, Few Will Attend Cancer Meetings

February 28, 1992

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009